Latham & Watkins Advises Sistema on its Acquisition of an Equity Interest in OBL Pharm
Sistema PJSFC, a publicly traded diversified Russian holding company, has acquired an equity interest in JSC Pharmaceutical Enterprise Obolenskoe (OBL Pharm), a leading Russian pharmaceutical company. The stake was acquired jointly with VTB Bank and members of the OBL Pharm management team. The investment consortium collectively acquired 95.14% of OBL Pharm for a total investment of RUB15.5 billion. The transaction represents a milestone in the creation of a major Russian pharmaceuticals group.